JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buck, K. J.
Right arrow Articles by Harris, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buck, K. J.
Right arrow Articles by Harris, R. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Club Drugs
Hazardous Substances DB
*ETHANOL
*FLUNITRAZEPAM
*TRITIUM

Benzodiazepine agonist and inverse agonist actions on GABAA receptor- operated chloride channels. II. Chronic effects of ethanol

KJ Buck and RA Harris

Department of Pharmacology, University of Colorado Health Sciences Center, Denver.

Mice were made tolerant to and dependent on ethanol by administration of a liquid diet. Gamma-aminobutyric acid (GABA) receptor-dependent uptake of 36Cl- by mouse cortical microsacs was used to study the actions of benzodiazepine (BZ) agonists and inverse agonists. Chronic exposure to ethanol attenuated the ability of a BZ agonist, flunitrazepam, to augment muscimol-stimulated uptake of 36Cl- and enhanced the actions of BZ inverse agonists, Ro15-4513 (ethyl-8-azido- 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,4]-benzodiazepine - 3- carboxylate) and DMCM (methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3- carboxylate), to inhibit GABAA receptor-operated chloride channels. Augmentation of chloride flux by pentobarbital was not reduced by chronic ethanol exposure. Attenuation of flunitrazepam efficacy was transient and returned to control levels within 6 to 24 hr after withdrawal from ethanol, but increased sensitivity to Ro15-4513 was observed as long as 8 days after withdrawal. Chronic exposure to ethanol did not alter [3H]SR 95531 ([2-(3'-carbethoxy-2'propyl)-3-amino- 6-p-methoxyphenylpyridazinium bromide] binding to low-affinity GABAA receptors or muscimol stimulation of chloride flux; and did not alter [3H]Ro15-4513 or [3H]flunitrazepam binding to central BZ receptors or allosteric modulation of this binding by muscimol (i.e., muscimol- shift). These results suggest that chronic exposure to ethanol reduces coupling between BZ agonist sites and the chloride channel, and may be responsible for the development of cross-tolerance between ethanol and BZ agonists. In contrast, coupling between BZ inverse agonist sites and the chloride channel is increased.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 253, Issue 2, pp. 713-719, 05/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Alcohol AlcoholHome page
C. Taylor, J. Nash, A. Rich, A. Lingford-Hughes, D. Nutt, and J. Potokar
Assessment of GABAA benzodiazepine receptor (GBzR) sensitivity in patients with alcohol dependence
Alcohol Alcohol., June 27, 2008; (2008) agn056v1.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. H. Krystal, J. Staley, G. Mason, I. L. Petrakis, J. Kaufman, R. A. Harris, J. Gelernter, and J. Lappalainen
{gamma}-Aminobutyric Acid Type A Receptors and Alcoholism: Intoxication, Dependence, Vulnerability, and Treatment.
Arch Gen Psychiatry, September 1, 2006; 63(9): 957 - 968.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. K. Staley, C. Gottschalk, I. L. Petrakis, R. Gueorguieva, S. O'Malley, R. Baldwin, P. Jatlow, N. P. L. G. Verhoeff, E. Perry, D. Weinzimmer, et al.
Cortical {gamma}-Aminobutyric Acid Type A-Benzodiazepine Receptors in Recovery From Alcohol Dependence: Relationship to Features of Alcohol Dependence and Cigarette Smoking
Arch Gen Psychiatry, August 1, 2005; 62(8): 877 - 888.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Liang, E. Cagetti, R. W. Olsen, and I. Spigelman
Altered Pharmacology of Synaptic and Extrasynaptic GABAA Receptors on CA1 Hippocampal Neurons Is Consistent with Subunit Changes in a Model of Alcohol Withdrawal and Dependence
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1234 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Sanna, M. C. Mostallino, F. Busonero, G. Talani, S. Tranquilli, M. Mameli, S. Spiga, P. Follesa, and G. Biggio
Changes in GABAA Receptor Gene Expression Associated with Selective Alterations in Receptor Function and Pharmacology after Ethanol Withdrawal
J. Neurosci., December 17, 2003; 23(37): 11711 - 11724.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Radel and D. Goldman
Pharmacogenetics of Alcohol Response and Alcoholism: The Interplay of Genes and Environmental Factors in Thresholds for Alcoholism
Drug Metab. Dispos., April 1, 2001; 29(4): 489 - 494.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. S. Reddy and M. A. Rogawski
Chronic Treatment with the Neuroactive Steroid Ganaxolone in the Rat Induces Anticonvulsant Tolerance to Diazepam but Not to Itself
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1241 - 1248.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. S. Reddy and M. A. Rogawski
Enhanced Anticonvulsant Activity of Ganaxolone after Neurosteroid Withdrawal in a Rat Model of Catamenial Epilepsy
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 909 - 915.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. A. Finn, E. J. Gallaher, and J. C. Crabbe
Differential Change in Neuroactive Steroid Sensitivity during Ethanol Withdrawal
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 394 - 405.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
K. L. Behar, D. L. Rothman, K. F. Petersen, M. Hooten, R. Delaney, O. A.C. Petroff, G. I. Shulman, V. Navarro, I. L. Petrakis, D. S. Charney, et al.
Preliminary Evidence of Low Cortical GABA Levels in Localized 1H-MR Spectra of Alcohol-Dependent and Hepatic Encephalopathy Patients
Am J Psychiatry, June 1, 1999; 156(6): 952 - 954.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
A. Abi-Dargham, J. H. Krystal, S. Anjilvel, B. E. Scanley, S. Zoghbi, R. M. Baldwin, N. Rajeevan, S. Ellis, I. L. Petrakis, J. P. Seibyl, et al.
Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [123I]Iomazenil
Am J Psychiatry, November 1, 1998; 155(11): 1550 - 1555.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
S. S. Smith, Q. H. Gong, X. Li, M. H. Moran, D. Bitran, C. A. Frye, and F.-C. Hsu
Withdrawal from 3alpha -OH-5alpha -Pregnan-20-One Using a Pseudopregnancy Model Alters the Kinetics of Hippocampal GABAA-Gated Current and Increases the GABAA Receptor alpha 4 Subunit in Association with Increased Anxiety
J. Neurosci., July 15, 1998; 18(14): 5275 - 5284.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. A. Harris, C. F. Valenzuela, S. Brozowski, L. Chuang, K. Hadingham, and P. J. Whiting
Adaptation of gamma -Aminobutyric Acid Type A Receptors to Alcohol Exposure: Studies with Stably Transfected Cells
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 180 - 188.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. Allan, H. Wu, L. L. Paxton, and D. D. Savage
Prenatal Ethanol Exposure Alters the Modulation of the gamma -Aminobutyric AcidA Receptor-Gated Chloride Ion Channel in Adult Rat Offspring
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 250 - 257.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.